News in brief: CBD anti-epileptic efficacy maintained for five years; Stroke risk from hypertension in pregnancy; Neurological disease burden in older Australians

Cannabidiol anti-seizure effect maintained for five years The efficacy of cannabidiol in reducing seizures among patients with refractory epilepsies is maintained during treatment up to 60 months, a US study has shown. A retrospective review of records for 54 people with refractory epilepsy who enrolled in the cannabidiol treatment program at Massachusetts General Hospital’s found that ...

Already a member?

Login to keep reading.

© 2022 the limbic